1. Home
  2. BIT vs PRME Comparison

BIT vs PRME Comparison

Compare BIT & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Multi-Sector Income Trust of Beneficial Interest

BIT

BlackRock Multi-Sector Income Trust of Beneficial Interest

N/A

Current Price

$11.14

Market Cap

645.4M

Sector

Finance

ML Signal

N/A

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

N/A

Current Price

$3.91

Market Cap

526.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BIT
PRME
Founded
N/A
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
645.4M
526.0M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
BIT
PRME
Price
$11.14
$3.91
Analyst Decision
Buy
Analyst Count
0
14
Target Price
N/A
★ $7.39
AVG Volume (30 Days)
333.0K
★ 5.3M
Earning Date
01-01-0001
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.18
EPS
★ N/A
N/A
Revenue
N/A
★ $4,632,000.00
Revenue This Year
N/A
$90.65
Revenue Next Year
N/A
$19.47
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 55.28
52 Week Low
$11.03
$2.67
52 Week High
$13.44
$5.91

Technical Indicators

Market Signals
Indicator
BIT
PRME
Relative Strength Index (RSI) 41.79 48.01
Support Level $11.06 $2.94
Resistance Level $11.40 $4.80
Average True Range (ATR) 0.12 0.56
MACD 0.01 -0.09
Stochastic Oscillator 20.78 15.60

Price Performance

Historical Comparison
BIT
PRME

About BIT BlackRock Multi-Sector Income Trust of Beneficial Interest

BlackRock Multi-Sector Income Trust is a closed-end investment management company. It invests on behalf of its clients. The fund's primary investment objective is to provide a high level of current income, with a secondary objective of capital appreciation. The company seeks to achieve its investment objectives by investing, under normal market conditions, a majority of its assets in loans and debt instruments and other investments with similar economic characteristics. Its portfolio consists of Corporate Bonds, Asset-Backed Securities, Preferred Securities, and others.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Share on Social Networks: